Suppr
超能文献

Cancer vaccines: pessimism in check.

作者信息

Mocellin Simone, Mandruzzato Susanna, Bronte Vincenzo, Marincola Francesco M

出版信息

Nat Med. 2004 Dec;10(12):1278-9; author reply 1279-80. doi: 10.1038/nm1204-1278.

DOI:10.1038/nm1204-1278

PMID:15580242

Abstract

摘要

相似文献

Cancer vaccines: pessimism in check.

Nat Med. 2004 Dec;10(12):1278-9; author reply 1279-80. doi: 10.1038/nm1204-1278.

Cancer vaccines: pessimism in check.

Nat Med. 2004 Dec;10(12):1279; author reply 1279-80. doi: 10.1038/nm1204-1279a.

Immunotherapy of metastasis.

Surg Oncol Clin N Am. 2001 Apr;10(2):433-47, xi.

Cellular and humoral immune responses of cancer patients to defined tumor antigens.

Cancer Chemother Biol Response Modif. 2001;19:385-93.

[Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].

Dtsch Med Wochenschr. 2001 Sep 14;126(37):1011-6. doi: 10.1055/s-2001-17111.

Cancer immunotherapy: a treatment for the masses.

Science. 2004 Jul 9;305(5681):200-5. doi: 10.1126/science.1100369.

A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.

Cancer Cytopathol. 2014 Jan;122(1):1-2. doi: 10.1002/cncy.21390.

Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.

Cancer J. 2011 Sep-Oct;17(5):325-30. doi: 10.1097/PPO.0b013e3182326004.

New frontiers in cell-based immunotherapy of cancer.

Expert Opin Ther Pat. 2009 May;19(5):623-41. doi: 10.1517/13543770902817820.

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.

Immunol Invest. 2006;35(3-4):359-94. doi: 10.1080/08820130600755009.

引用本文的文献

Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update.

Pharmaceutics. 2020 Jan 23;12(2):92. doi: 10.3390/pharmaceutics12020092.

Current clinical trials for melanoma vaccines: where do we stand?

Melanoma Manag. 2016 Dec;3(4):255-257. doi: 10.2217/mmt-2016-0009. Epub 2016 Nov 30.

Reflections upon human cancer immune responsiveness to T cell-based therapy.

Cancer Immunol Immunother. 2012 Jun;61(6):761-70. doi: 10.1007/s00262-012-1274-9. Epub 2012 May 11.

Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review.

J Transl Med. 2011 Jan 27;9:17. doi: 10.1186/1479-5876-9-17.

Analysis of vaccine-induced T cells in humans with cancer.

Adv Exp Med Biol. 2010;684:178-88. doi: 10.1007/978-1-4419-6451-9_14.

Clinical applications of a peptide-based vaccine for glioblastoma.

Neurosurg Clin N Am. 2010 Jan;21(1):95-109. doi: 10.1016/j.nec.2009.09.001.

EGFRvIII-targeted vaccination therapy of malignant glioma.

Brain Pathol. 2009 Oct;19(4):713-23. doi: 10.1111/j.1750-3639.2009.00318.x.

Progress and challenges in the vaccine-based treatment of head and neck cancers.

J Exp Clin Cancer Res. 2009 May 27;28(1):69. doi: 10.1186/1756-9966-28-69.

Anaplastic lymphoma kinase: an oncogene for tumor vaccination.

J Mol Med (Berl). 2009 Jul;87(7):669-77. doi: 10.1007/s00109-009-0460-5. Epub 2009 Mar 30.

Lectin of Concanavalin A as an anti-hepatoma therapeutic agent.

J Biomed Sci. 2009 Jan 19;16(1):10. doi: 10.1186/1423-0127-16-10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cancer vaccines: pessimism in check.

Nat Med. 2004 Dec;10(12):1278-9; author reply 1279-80. doi: 10.1038/nm1204-1278.

Cancer vaccines: pessimism in check.

Nat Med. 2004 Dec;10(12):1279; author reply 1279-80. doi: 10.1038/nm1204-1279a.

Immunotherapy of metastasis.

Surg Oncol Clin N Am. 2001 Apr;10(2):433-47, xi.

Cellular and humoral immune responses of cancer patients to defined tumor antigens.

Cancer Chemother Biol Response Modif. 2001;19:385-93.

[Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].

Dtsch Med Wochenschr. 2001 Sep 14;126(37):1011-6. doi: 10.1055/s-2001-17111.

Cancer immunotherapy: a treatment for the masses.

Science. 2004 Jul 9;305(5681):200-5. doi: 10.1126/science.1100369.

A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.

Cancer Cytopathol. 2014 Jan;122(1):1-2. doi: 10.1002/cncy.21390.

Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.

Cancer J. 2011 Sep-Oct;17(5):325-30. doi: 10.1097/PPO.0b013e3182326004.

New frontiers in cell-based immunotherapy of cancer.

Expert Opin Ther Pat. 2009 May;19(5):623-41. doi: 10.1517/13543770902817820.

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.

Immunol Invest. 2006;35(3-4):359-94. doi: 10.1080/08820130600755009.

引用本文的文献

Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update.

Pharmaceutics. 2020 Jan 23;12(2):92. doi: 10.3390/pharmaceutics12020092.

Current clinical trials for melanoma vaccines: where do we stand?

Melanoma Manag. 2016 Dec;3(4):255-257. doi: 10.2217/mmt-2016-0009. Epub 2016 Nov 30.

Reflections upon human cancer immune responsiveness to T cell-based therapy.

Cancer Immunol Immunother. 2012 Jun;61(6):761-70. doi: 10.1007/s00262-012-1274-9. Epub 2012 May 11.

Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review.

J Transl Med. 2011 Jan 27;9:17. doi: 10.1186/1479-5876-9-17.

Analysis of vaccine-induced T cells in humans with cancer.

Adv Exp Med Biol. 2010;684:178-88. doi: 10.1007/978-1-4419-6451-9_14.

Clinical applications of a peptide-based vaccine for glioblastoma.

Neurosurg Clin N Am. 2010 Jan;21(1):95-109. doi: 10.1016/j.nec.2009.09.001.

EGFRvIII-targeted vaccination therapy of malignant glioma.

Brain Pathol. 2009 Oct;19(4):713-23. doi: 10.1111/j.1750-3639.2009.00318.x.

Progress and challenges in the vaccine-based treatment of head and neck cancers.

J Exp Clin Cancer Res. 2009 May 27;28(1):69. doi: 10.1186/1756-9966-28-69.

Anaplastic lymphoma kinase: an oncogene for tumor vaccination.

J Mol Med (Berl). 2009 Jul;87(7):669-77. doi: 10.1007/s00109-009-0460-5. Epub 2009 Mar 30.

Lectin of Concanavalin A as an anti-hepatoma therapeutic agent.

J Biomed Sci. 2009 Jan 19;16(1):10. doi: 10.1186/1423-0127-16-10.

Suppr超能文献

Cancer vaccines: pessimism in check.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译